[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

How is Mucosa-Associated Lymphoid Tissue Lymphoma Staged and Classified?

Mucosa-Associated Lymphoid Tissue (MALT) lymphoma is staged and classified based on various factors, including the extent of disease involvement, the location of the lymphoma, and its histological subtype. Staging and classification help determine the prognosis and guide treatment decisions. 

The staging system commonly used for MALT lymphoma is the Ann Arbor staging system, which is also used for other types of non-Hodgkin lymphoma. Here's an overview of how MALT lymphoma is staged and classified:

Staging of MALT Lymphoma:

  • Stage I: The lymphoma is limited to a single lymph node region or a single extralymphatic organ or site (e.g., one lung, one eye, one salivary gland, or the stomach).
  • Stage II: The lymphoma involves two or more lymph node regions on the same side of the diaphragm or one lymph node region and an extralymphatic organ or site.
  • Stage III: The lymphoma is present on both sides of the diaphragm, potentially involving multiple lymph node regions or extralymphatic organs/sites.
  • Stage IV: The lymphoma has spread extensively to one or more extralymphatic organs (other lymphatic structures), such as the bone marrow, liver, lungs, or other organs.

Further Classification:

In addition to the numerical staging, MALT lymphoma may also be further classified based on the location and specific organ involvement. For example, it may be categorized as gastric MALT lymphoma (if it primarily involves the stomach), pulmonary MALT lymphoma (if it primarily involves the lungs), or ocular MALT lymphoma (if it primarily affects the eyes).

Histological Classification of MALT Lymphoma:

MALT lymphoma can arise from B cells, and the specific histological subtype can vary. Common subtypes include:

  • Marginal Zone B-cell Lymphoma: This is the most common subtype of MALT lymphoma. It typically consists of small B cells that have characteristics of marginal zone lymphocytes.
    • B cells: are a type of white blood cell (lymphocyte) that is a crucial component of the immune system. They are primarily responsible for producing antibodies, which are proteins that can recognize and bind to specific foreign substances (antigens) such as bacteria, viruses, and other pathogens.
    • Marginal zone lymphocytes: also known as marginal zone B cells or marginal zone lymphoid cells, play a significant role in Mucosa-Associated Lymphoid Tissue (MALT) lymphoma, as well as in the immune system more broadly. Targeting and eliminating these malignant cells is a key aspect of MALT lymphoma treatment.
  • Follicular Lymphoma with MALT Phenotype: In some cases, MALT lymphoma may have features that overlap with follicular lymphoma. Follicular lymphoma is the most common type of of low-grade non-Hodgkin lymphoma (NHL). It develops when white blood cells cluster together to form lumps in your lymph glands or organs.
  • MALT Lymphoma with Large Cells: A small subset of MALT lymphomas may have large or transformed cells, which can affect treatment decisions.

Classification Based on Genetic and Molecular Characteristics:

Recent advances in understanding the genetic and molecular features of MALT lymphoma have led to further classification and subclassification based on specific genetic abnormalities or mutations. These classifications may provide additional information about the behavior of the lymphoma and potential targeted treatment options.

It's important to note that the staging, classification, and specific treatment approach for MALT lymphoma should be determined by a healthcare provider experienced in the management of lymphomas. A thorough evaluation, including imaging studies, biopsies, and laboratory tests, is essential for accurate staging and classification. Once the lymphoma is accurately staged and classified, healthcare providers can develop an individualized treatment plan tailored to the patient's unique circumstances.

 

Want to learn more about Mucosa-associated lymphoid tissue lymphoma? 

Keep reading Healthtree’s MALT Lymphoma 101 pages!

What are treatments for mucosa-associated lymphoid tissue lymphoma?

What are the signs and symptoms of mucosa-associated lymphoid tissue lymphoma?

How long will I live with mucosa-associated lymphoid tissue lymphoma?

How is mucosa-associated lymphoid tissue lymphoma diagnosed??

What is mucosa-associated lymphoid tissue (MALT) lymphoma??

 

How is Mucosa-Associated Lymphoid Tissue Lymphoma Staged and Classified?

Mucosa-Associated Lymphoid Tissue (MALT) lymphoma is staged and classified based on various factors, including the extent of disease involvement, the location of the lymphoma, and its histological subtype. Staging and classification help determine the prognosis and guide treatment decisions. 

The staging system commonly used for MALT lymphoma is the Ann Arbor staging system, which is also used for other types of non-Hodgkin lymphoma. Here's an overview of how MALT lymphoma is staged and classified:

Staging of MALT Lymphoma:

  • Stage I: The lymphoma is limited to a single lymph node region or a single extralymphatic organ or site (e.g., one lung, one eye, one salivary gland, or the stomach).
  • Stage II: The lymphoma involves two or more lymph node regions on the same side of the diaphragm or one lymph node region and an extralymphatic organ or site.
  • Stage III: The lymphoma is present on both sides of the diaphragm, potentially involving multiple lymph node regions or extralymphatic organs/sites.
  • Stage IV: The lymphoma has spread extensively to one or more extralymphatic organs (other lymphatic structures), such as the bone marrow, liver, lungs, or other organs.

Further Classification:

In addition to the numerical staging, MALT lymphoma may also be further classified based on the location and specific organ involvement. For example, it may be categorized as gastric MALT lymphoma (if it primarily involves the stomach), pulmonary MALT lymphoma (if it primarily involves the lungs), or ocular MALT lymphoma (if it primarily affects the eyes).

Histological Classification of MALT Lymphoma:

MALT lymphoma can arise from B cells, and the specific histological subtype can vary. Common subtypes include:

  • Marginal Zone B-cell Lymphoma: This is the most common subtype of MALT lymphoma. It typically consists of small B cells that have characteristics of marginal zone lymphocytes.
    • B cells: are a type of white blood cell (lymphocyte) that is a crucial component of the immune system. They are primarily responsible for producing antibodies, which are proteins that can recognize and bind to specific foreign substances (antigens) such as bacteria, viruses, and other pathogens.
    • Marginal zone lymphocytes: also known as marginal zone B cells or marginal zone lymphoid cells, play a significant role in Mucosa-Associated Lymphoid Tissue (MALT) lymphoma, as well as in the immune system more broadly. Targeting and eliminating these malignant cells is a key aspect of MALT lymphoma treatment.
  • Follicular Lymphoma with MALT Phenotype: In some cases, MALT lymphoma may have features that overlap with follicular lymphoma. Follicular lymphoma is the most common type of of low-grade non-Hodgkin lymphoma (NHL). It develops when white blood cells cluster together to form lumps in your lymph glands or organs.
  • MALT Lymphoma with Large Cells: A small subset of MALT lymphomas may have large or transformed cells, which can affect treatment decisions.

Classification Based on Genetic and Molecular Characteristics:

Recent advances in understanding the genetic and molecular features of MALT lymphoma have led to further classification and subclassification based on specific genetic abnormalities or mutations. These classifications may provide additional information about the behavior of the lymphoma and potential targeted treatment options.

It's important to note that the staging, classification, and specific treatment approach for MALT lymphoma should be determined by a healthcare provider experienced in the management of lymphomas. A thorough evaluation, including imaging studies, biopsies, and laboratory tests, is essential for accurate staging and classification. Once the lymphoma is accurately staged and classified, healthcare providers can develop an individualized treatment plan tailored to the patient's unique circumstances.

 

Want to learn more about Mucosa-associated lymphoid tissue lymphoma? 

Keep reading Healthtree’s MALT Lymphoma 101 pages!

What are treatments for mucosa-associated lymphoid tissue lymphoma?

What are the signs and symptoms of mucosa-associated lymphoid tissue lymphoma?

How long will I live with mucosa-associated lymphoid tissue lymphoma?

How is mucosa-associated lymphoid tissue lymphoma diagnosed??

What is mucosa-associated lymphoid tissue (MALT) lymphoma??

 

newsletter icon

Get the latest thought leadership on your Mucosa-Associated Lymphoid Tissue Lymphoma delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.